Palamedrix Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $52.5M

  • Investors
  • 1

Palamedrix General Information

Description

Developer of a multi-omic platform designed to accelerate advancements in life science and medicine. The company's platform leverages DNA nanotechnology to develop solutions for biomedical applications by providing comprehensive data, thereby enabling doctors and patients to get an accurate and complete view of an individual's biochemistry with a single test.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 652 Jocelyn Way
  • Encinitas, CA 92024
  • United States
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 652 Jocelyn Way
  • Encinitas, CA 92024
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Palamedrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 31-Aug-2022 $52.5M Completed Startup
3. Seed Round 22-Jan-2021 Completed Startup
2. Seed Round 01-Jan-2020 Completed Startup
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Palamedrix’s complete valuation and funding history, request access »

Palamedrix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a multi-omic platform designed to accelerate advancements in life science and medicine. The company's platf
Biotechnology
Encinitas, CA
13 As of 2022

San Diego, CA
 

McLean, VA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Palamedrix Competitors (15)

One of Palamedrix’s 15 competitors is Encodia, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Encodia Venture Capital-Backed San Diego, CA
Perthera Venture Capital-Backed McLean, VA
Nautilus Biotechnology Formerly VC-backed Seattle, WA
NeuroSky Formerly VC-backed San Jose, CA
Nanobiotix Formerly VC-backed Paris, France
You’re viewing 5 of 15 competitors. Get the full list »

Palamedrix Patents

Palamedrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023049355-A1 Monofunctional particles Inactive 23-Sep-2021
WO-2022251514-A1 Solution phase single molecule capture and associated techniques Inactive 27-May-2021
WO-2022212479-A2 Integration of a protein colocalization device (pcd) onto a microfluidic device Inactive 31-Mar-2021
WO-2022182635-A1 Structure and methods for detection of sample analytes Inactive 24-Feb-2021
WO-2022182643-A1 Structure and methods for detection of sample analytes Inactive 23-Feb-2021 G01N33/54366
To view Palamedrix’s complete patent history, request access »

Palamedrix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Palamedrix Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
California Institute of Technology Endowment Limited Partner Minority
Casdin Capital Venture Capital Minority
Civilization Ventures Venture Capital Minority
Formic Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Palamedrix FAQs

  • When was Palamedrix founded?

    Palamedrix was founded in 2017.

  • Where is Palamedrix headquartered?

    Palamedrix is headquartered in Encinitas, CA.

  • What is the size of Palamedrix?

    Palamedrix has 13 total employees.

  • What industry is Palamedrix in?

    Palamedrix’s primary industry is Biotechnology.

  • Is Palamedrix a private or public company?

    Palamedrix is a Private company.

  • What is the current valuation of Palamedrix?

    The current valuation of Palamedrix is .

  • What is Palamedrix’s current revenue?

    The current revenue for Palamedrix is .

  • Who are Palamedrix’s investors?

    , California Institute of Technology Endowment, Casdin Capital, Civilization Ventures, and Formic Ventures are 5 of 10 investors who have invested in Palamedrix.

  • Who are Palamedrix’s competitors?

    Encodia, Perthera, Nautilus Biotechnology, NeuroSky, and Nanobiotix are some of the 15 competitors of Palamedrix.

  • When was Palamedrix acquired?

    Palamedrix was acquired on 31-Aug-2022.

  • Who acquired Palamedrix?

    Palamedrix was acquired by SomaLogic Operating Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process